|
BTF3L4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.514600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.224000E-01 |
| Normal-vs-Stage2 |
7.556400E-01 |
| Normal-vs-Stage3 |
9.484000E-01 |
| Normal-vs-Stage4 |
8.823400E-01 |
| Stage1-vs-Stage2 |
9.746600E-01 |
| Stage1-vs-Stage3 |
7.080600E-01 |
| Stage1-vs-Stage4 |
7.370000E-01 |
| Stage2-vs-Stage3 |
7.963400E-01 |
| Stage2-vs-Stage4 |
8.310000E-01 |
| Stage3-vs-Stage4 |
9.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.361200E-01 |
| Normal-vs-AfricanAmerican |
4.059500E-02 |
| Normal-vs-Asian |
7.904600E-01 |
| Caucasian-vs-AfricanAmerican |
7.649200E-04 |
| Caucasian-vs-Asian |
9.686800E-01 |
| AfricanAmerican-vs-Asian |
1.576170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.973000E-01 |
| Normal-vs-Female |
4.888200E-01 |
| Male-vs-Female |
4.207600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.924000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.432400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.438600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.886200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.660800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.535400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.273000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.663000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.664600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.160200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.463200E-01 |
| Normal-vs-Grade 2 |
1.884170E-01 |
| Normal-vs-Grade 3 |
3.678200E-01 |
| Normal-vs-Grade 4 |
9.671000E-01 |
| Grade 1-vs-Grade 2 |
9.492800E-01 |
| Grade 1-vs-Grade 3 |
1.682020E-01 |
| Grade 1-vs-Grade 4 |
4.454400E-01 |
| Grade 2-vs-Grade 3 |
5.835500E-03 |
| Grade 2-vs-Grade 4 |
1.740760E-01 |
| Grade 3-vs-Grade 4 |
4.331400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.832300E-02 |
| Normal-vs-ccB subtype |
7.790600E-01 |
| ccA subtype-vs-ccB subtype |
1.782000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.830600E-01 |
| Normal-vs-N1 |
6.785400E-01 |
| N0-vs-N1 |
9.488600E-01 |
|
|
